Anthony Murray

Strategic growth leader with 15+ years' experience operating at the intersection of life sciences intelligence, CRO commercialisation and enterprise marketing architecture. Began career scaling international healthcare research businesses at GlobalData Life Sciences, before transitioning into operational CRO build and commercial leadership roles. Currently architecting franchise-level growth strategy within a global CRO, integrating competitive intelligence, AI-enabled insight systems and scientific-to-commercial translation to drive differentiated market positioning and pipeline impact.

Combines data fluency, therapeutic depth and cross-functional influence to design scalable growth frameworks aligned to long-term enterprise ambition.

Director, Marketing Strategy at Worldwide Clinical Trials LLC (2025-03 – 2026-05)

Lead enterprise-level marketing and franchise growth strategy across Oncology (incl. CGT, Radiopharma, ADCs), Neurosciences, Cardiovascular and Metabolic portfolios within a global CRO.

• Architected annual and multi-year franchise growth frameworks aligned to corporate ambition to materially scale bookings and revenue
• Designed and embedded structured marketing governance cadence integrating Therapeutic Strategy Leads, BD and Corporate Marketing
• Developed differentiated TA- and modality-level messaging matrices grounded in sponsor decision drivers and operational capability
• Built centralised proof-point governance library to strengthen RFP competitiveness and global sales enablement
• Implemented structured competitive intelligence and counter-messaging frameworks across priority therapeutic areas
• Integrated AI-enabled analysis and RAG-style knowledge frameworks to enhance proposal mining, messaging refinement and insight synthesis
• Established KPI architecture linking awareness, engagement and content effectiveness to pipeline influence and executive reporting
• Designed and led structured primary and secondary market insight processes to inform global franchise positioning and go-to-market strategy
• Partnered with Commercial leadership to build inaugural go-to-market strategy for expanded service offerings
• Aligned conference strategy (e.g., ASCO integration) with franchise positioning and ABM priorities
• Delivered executive-level performance storytelling and optimisation recommendations

Head of Growth at Opyl Limited (2022-02 – 2024-04)

Owned end-to-end growth strategy across B2B and B2C lines, including Opin (research recruitment), Opin.AI (participant engagement platform) and TrialKey (AI-driven protocol planning analytics). Reference: CEO, Michelle Gallaher

• Secured MSAs and commercial agreements with five top-tier global pharmaceutical sponsors
• Led commercial launch and market positioning of Opin.AI 2.0, integrating AI-driven participant engagement capabilities
• Expanded service footprint into US market, establishing cross-border commercial partnerships
• Reported directly to board and investors on revenue performance, pipeline growth, product roadmap and strategic expansion
• Designed and implemented go-to-market architecture, account management framework and internal growth hiring strategy
• Originated partnership and M&A opportunities; supported due diligence and strategic evaluation

Partnerships Director & Co-Founder at Ventri Clinical (2021-02 – 2022-01)

Facilitated by the Australian Cardiovascular Alliance (ACvA) and supported by MTPConnect, the federal agency responsible for innovation and growth in science, supported the start-up of a clinical network for First-In-Human studies of novel cardiovascular technologies. Ventri Clinical provides a lens and commercialization for clinicians, sites and services into Cardiovascular clinical device trials in Australia. Reference: CEO, Kerry Doyle

Executive Director – Marketing, Business Development & Proposals at GreenLight Clinical Pty Limited (2020-02 – 2020-11)

Appointed in start-up phase of international CRO to architect global commercial strategy, BD systems and marketing infrastructure across Australia, USA, China and UK operations. Therapeutic focus included Ophthalmology and Oncology clinical development.

• Designed and implemented global commercial and marketing strategy during early-stage CRO scale-up
• Built Salesforce CRM architecture and performance reporting framework from inception
• Established proposals governance structure, SOPs and budget optimisation processes aligned to clinical operations capacity
• Integrated Oncology and Ophthalmology therapeutic positioning into international go-to-market strategy
• Led development of corporate messaging, website launch and agency engagement to establish global brand credibility
• Reported directly to board and investors on revenue targets, pipeline development and COVID-adjusted strategic plan
• Coordinated closely with Clinical Operations leadership to align resource forecasting, service positioning and client engagement protocols
• Recalibrated 2020–2021 FY strategy in response to COVID disruption, protecting revenue trajectory and operational resilience
• Recruited, onboarded and structured international BD and proposals team capability

Regional Director, APAC at GlobalData PLC (2013-12 – 2020-02)

Leading GlobalData's Life Sciences teams in Asia, role evolved to assume operational and revenue responsibilities across teams in Australia, Singapore, Japan, Shanghai, Korea and India. This grew to a US$6.9M business in 2019 (growth from US$6M 2018) and a further US$3.5M in 'dotted-line' support across GlobalData Healthcare, Consumer and Retail divisions. Reference: President APAC, Justin Inglis

• Strategic planning and execution of regional revenue objectives
• Supporting research teams in prioritizing/shaping analysis to international focuses and clientele
• Incentivizing, training, onboarding and motivating Business Development teams across varied locations/cultures
• Planning and executing marketing strategies to suit and target unique territories with limited budget
• Sourcing and collaborating with international industry bodies and events to best promote brand and sales opportunities
• Managing day-to-day access/usage of facilities, IT, CRM and other internal systems
• Client contract legalities
• Driving development of group internal communications strategy

Director, Key Accounts at GlobalData PLC (2009-07 – 2013-11)

Senior Associate at Corporate Executive Board Limited (now Gartner) (2007-09 – 2008-08)

BA in English Literature with German Studies – Oxford Brookes University (2003 – 2006)